• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用A群和C群脑膜炎球菌多糖疫苗免疫儿童后抗体的持续性。

Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines.

作者信息

Lepow M L, Goldschneider I, Gold R, Randolph M, Gotschlich E C

出版信息

Pediatrics. 1977 Nov;60(5):673-80.

PMID:411104
Abstract

Persistence of antibody following immunization with groups A and C meningococcal polysaccharides was studied in two groups of children. Cohort 1 (20 children, 2 to 11 years of age) received two doses of A vaccine three years apart; cohort 2 (1,345 children, 6 to 8 years of age) received A or C vaccine initially and the heterologous vaccine one year later. No significant reactions were observed. Geometric mean anti-A concentrations one month after primary and booster immunization in cohort 1 were 8.77 and 13.08 microgram/ml, respectively. Mean anti-A concentration declined 32% one year after booster immunization, but then stabilized. Mean anti-A and anti-C concentrations in cohort 2 were 9.35 and 9.12 microgram/ml, respectively, one month after primary immunization. Mean anti-A concentration declined to 5.54 and 3.62 microgram/ml while anti-C levels fell to 2.35 and 1.47 microgram/ml one and four years after immunization. The proportion of children in cohort 2 with greater than or equal to 2.0 microgram/ml of anti-A and anti-C four years after immunization were 80% and 40%, respectively. An antibody concentration greater than or equal to 2.0 microgram/ml has been associated with protection against meningococcal disease. The results suggest that routine immunization of young infants with group A vaccine may result in long-lasting immunity. The usefulness of the presently available group C vaccine appears to be limited to the control of epidemics.

摘要

在两组儿童中研究了用A群和C群脑膜炎球菌多糖免疫后抗体的持续性。队列1(20名2至11岁儿童)每隔三年接种两剂A疫苗;队列2(1345名6至8岁儿童)最初接种A疫苗或C疫苗,一年后接种异源疫苗。未观察到明显反应。队列1初次免疫和加强免疫后1个月的几何平均抗A浓度分别为8.77和13.08微克/毫升。加强免疫后1年,平均抗A浓度下降32%,但随后趋于稳定。队列2初次免疫后1个月的平均抗A和抗C浓度分别为9.35和9.12微克/毫升。免疫后1年和4年,平均抗A浓度分别降至5.54和3.62微克/毫升,而抗C水平分别降至2.35和1.47微克/毫升。队列2中免疫后4年抗A和抗C浓度大于或等于2.0微克/毫升的儿童比例分别为80%和40%。抗A浓度大于或等于2.0微克/毫升与预防脑膜炎球菌病有关。结果表明,对幼儿常规接种A群疫苗可能会产生持久免疫力。目前可用的C群疫苗的用途似乎仅限于控制疫情。

相似文献

1
Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines.用A群和C群脑膜炎球菌多糖疫苗免疫儿童后抗体的持续性。
Pediatrics. 1977 Nov;60(5):673-80.
2
Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.对最初在15至24个月龄时进行免疫接种的儿童,用b型流感嗜血杆菌多糖和多糖-白喉类毒素结合疫苗再次免疫后的抗体持续性及加强免疫反应。
Pediatrics. 1990 Mar;85(3):288-93.
3
Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants.A群和C群脑膜炎球菌多糖疫苗在婴儿中的临床评估
J Clin Invest. 1975 Dec;56(6):1536-47. doi: 10.1172/JCI108235.
4
Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides.两种四价(ACYW135)脑膜炎球菌疫苗在婴幼儿中的评估:一项比较O-乙酰基阴性和O-乙酰基阳性C群多糖免疫原性的临床研究。
Pediatrics. 1985 Jul;76(1):91-6.
5
Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.婴儿期接种A/C群脑膜炎球菌结合疫苗5年后的免疫记忆
J Infect Dis. 2001 Jan 1;183(1):97-104. doi: 10.1086/317667. Epub 2000 Nov 15.
6
Long-term protection in children with meningococcal C conjugate vaccination: lessons learned.脑膜炎球菌C结合疫苗对儿童的长期保护:经验教训
Expert Rev Vaccines. 2006 Dec;5(6):851-7. doi: 10.1586/14760584.5.6.851.
7
Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children.
J Infect Dis. 1979 Nov;140(5):690-7. doi: 10.1093/infdis/140.5.690.
8
Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children.既往脑膜炎球菌C多糖疫苗接种对幼儿接种脑膜炎球菌C结合疫苗后反应及记忆产生的影响。
J Infect Dis. 2001 Aug 1;184(3):377-80. doi: 10.1086/322024. Epub 2001 Jul 10.
9
Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory.脑膜炎球菌C群结合疫苗在婴儿期具有免疫原性并能激发免疫记忆。
J Infect Dis. 1999 Jun;179(6):1569-72. doi: 10.1086/314753.
10
Safety and immunogenicity of subcutaneous H. influenzae vaccines in 15-17 month-old children.15至17月龄儿童皮下注射流感嗜血杆菌疫苗的安全性和免疫原性。
Clin Invest Med. 1991 Oct;14(5):379-87.

引用本文的文献

1
High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.B细胞对四价脑膜炎球菌结合疫苗和平价多糖疫苗反应的高维评估
Genome Med. 2017 Jan 30;9(1):11. doi: 10.1186/s13073-017-0400-x.
2
Designing vaccines for the twenty-first century society.为21世纪社会设计疫苗。
Front Immunol. 2014 Jan 23;5:12. doi: 10.3389/fimmu.2014.00012. eCollection 2014.
3
Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: A decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type during the period from 2002 to 2009.
加拿大侵袭性 C 群脑膜炎奈瑟菌的遗传和抗原分析:2002 年至 2009 年期间,电泳型(ET)-15 克隆型的比例下降,而属于 ET-37(而非 ET-15)克隆型的分离株比例增加。
Can J Infect Dis Med Microbiol. 2012 Fall;23(3):e55-9. doi: 10.1155/2012/131328.
4
Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccine.实验室工作人员接种四价脑膜炎球菌多糖疫苗后抗体的持久性。
J Occup Med Toxicol. 2013 Mar 4;8(1):4. doi: 10.1186/1745-6673-8-4.
5
Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A/C polysaccharide vaccine in adults.一剂A群脑膜炎球菌结合疫苗或A/C多糖疫苗接种后成人不同A群免疫测定法的研究
Clin Vaccine Immunol. 2009 Jul;16(7):969-77. doi: 10.1128/CVI.00068-09. Epub 2009 May 27.
6
Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.A、C、Y及W-135群脑膜炎球菌多糖蛋白结合疫苗
Arch Dis Child. 2007 Oct;92(10):909-15. doi: 10.1136/adc.2006.111500.
7
Prospects for vaccine prevention of meningococcal infection.脑膜炎球菌感染疫苗预防的前景。
Clin Microbiol Rev. 2006 Jan;19(1):142-64. doi: 10.1128/CMR.19.1.142-164.2006.
8
Surface plasmon resonance analysis of antipolysaccharide antibody specificity: responses to meningococcal group C conjugate vaccines and bacteria.抗多糖抗体特异性的表面等离子体共振分析:对脑膜炎球菌C群结合疫苗和细菌的反应
Infect Immun. 2004 Jun;72(6):3451-60. doi: 10.1128/IAI.72.6.3451-3460.2004.
9
Murine immune response to Neisseria meningitidis group C capsular polysaccharide: analysis of monoclonal antibodies generated in response to a thymus-independent antigen and a thymus-dependent toxoid conjugate vaccine.小鼠对C群脑膜炎奈瑟菌荚膜多糖的免疫反应:针对非胸腺依赖性抗原和胸腺依赖性类毒素结合疫苗产生的单克隆抗体分析
Infect Immun. 2000 Jan;68(1):239-46. doi: 10.1128/IAI.68.1.239-246.2000.
10
Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine.小鼠对C群脑膜炎奈瑟菌荚膜多糖和一种胸腺依赖性类毒素结合疫苗的免疫反应。
Infect Immun. 1998 Nov;66(11):5450-6. doi: 10.1128/IAI.66.11.5450-5456.1998.